Schadendorf D - Search Results

1

[Adjuvant interferon-alpha therapy of malignant melanoma. Position of the Dermatologic Oncology Working Group].

Hauschild A, Dummer R, Garbe C, Kaufmann R, Schadendorf D, Soyer HP, Stadler R, Tilgen W. Hauschild A, et al. Among authors: schadendorf d. Hautarzt. 1998 Mar;49(3):167-9. doi: 10.1007/s001050050722. Hautarzt. 1998. PMID: 9565782 German. No abstract available.

2

[Interleukin 7 in dermatology. Molecular, immunologic and preclinical aspects].

Möller P, Czarnetzki BM, Schadendorf D. Möller P, et al. Among authors: schadendorf d. Hautarzt. 1995 Oct;46(10):676-82. doi: 10.1007/s001050050321. Hautarzt. 1995. PMID: 7499126 Review. German.

3

[Drug resistance of malignant melanoma. Mechanisms and possible modulation].

Schadendorf D, Czarnetzki BM. Schadendorf D, et al. Hautarzt. 1994 Oct;45(10):678-84. doi: 10.1007/s001050050149. Hautarzt. 1994. PMID: 8002335 Review. German.

4

Verrucous cysts: histopathologic characterization and molecular detection of human papillomavirus-specific DNA.

Soyer HP, Schadendorf D, Cerroni L, Kerl H. Soyer HP, et al. Among authors: schadendorf d. J Cutan Pathol. 1993 Oct;20(5):411-7. doi: 10.1111/j.1600-0560.1993.tb00663.x. J Cutan Pathol. 1993. PMID: 8300926

5

[Comment on the contribution by J. Petres et al. Effective lymph node dissection in primary malignant melanoma].

Schadendorf D. Schadendorf D. Hautarzt. 1996 Sep;47(9):722-3. doi: 10.1007/s001050050499. Hautarzt. 1996. PMID: 8999033 German. No abstract available.

6

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.

Keilholz U, Goey SH, Punt CJ, Proebstle TM, Salzmann R, Scheibenbogen C, Schadendorf D, Liénard D, Enk A, Dummer R, Hantich B, Geueke AM, Eggermont AM. Keilholz U, et al. Among authors: schadendorf d. J Clin Oncol. 1997 Jul;15(7):2579-88. doi: 10.1200/JCO.1997.15.7.2579. J Clin Oncol. 1997. PMID: 9215828 Free article. Clinical Trial.

7

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.

Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D. Nestle FO, et al. Among authors: schadendorf d. Nat Med. 1998 Mar;4(3):328-32. doi: 10.1038/nm0398-328. Nat Med. 1998. PMID: 9500607 Clinical Trial.

8

CD44 variant isoform expression in a variety of skin-associated autoimmune diseases.

Seiter S, Schadendorf D, Tilgen W, Zöller M. Seiter S, et al. Among authors: schadendorf d. Clin Immunol Immunopathol. 1998 Oct;89(1):79-93. doi: 10.1006/clin.1998.4565. Clin Immunol Immunopathol. 1998. PMID: 9756727

9

Expression of CD44 variant isoforms in malignant melanoma.

Seiter S, Schadendorf D, Herrmann K, Schneider M, Rösel M, Arch R, Tilgen W, Zöller M. Seiter S, et al. Among authors: schadendorf d. Clin Cancer Res. 1996 Mar;2(3):447-56. Clin Cancer Res. 1996. PMID: 9816190

10

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.

Middleton MR, Grob JJ, Aaronson N, Fierlbeck G, Tilgen W, Seiter S, Gore M, Aamdal S, Cebon J, Coates A, Dreno B, Henz M, Schadendorf D, Kapp A, Weiss J, Fraass U, Statkevich P, Muller M, Thatcher N. Middleton MR, et al. Among authors: schadendorf d. J Clin Oncol. 2000 Jan;18(1):158-66. doi: 10.1200/JCO.2000.18.1.158. J Clin Oncol. 2000. PMID: 10623706 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,106 results

Search Page

Filters